Bliss GVS Pharma Limited
Bliss GVS Pharma Limited
Share · INE416D01022 (XNSE)
Overview
No Price
Closing Price XNSE 18.03.2026: 215,41 INR
18.03.2026 09:59
Current Prices from Bliss GVS Pharma Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XNSE: NSE
NSE
BLISSGVS.NS
INR
18.03.2026 09:59
215,41 INR
4,65 INR
+2,21 %
XBOM: MSE
MSE
BLISSGVS.BO
INR
18.03.2026 09:59
215,80 INR
5,04 INR
+2,39 %
Share Float & Liquidity
Free Float 40,01 %
Shares Float 42,33 M
Shares Outstanding 105,79 M
Company Profile for Bliss GVS Pharma Limited Share
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as soaps. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
AI Analysis of Bliss GVS Pharma Limited
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of Bliss GVS Pharma Limited
No AI threads available for this company yet.

Company Data

Name Bliss GVS Pharma Limited
Company Bliss GVS Pharma Limited
Website https://www.blissgvs.com
Primary Exchange XNSE NSE
ISIN INE416D01022
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Shibroor Narsimha Kamath
Market Capitalization 23 Mrd.
Country India
Currency INR
Employees 0,8 T
Address 102, Hyde Park, 400072 Mumbai
IPO Date 2002-01-11
Dividends from 'Bliss GVS Pharma Limited'
Ex-Date Dividend per Share
18.02.2026 0,50 INR
24.07.2025 0,50 INR
18.07.2024 0,50 INR
12.07.2023 43,28 INR
20.06.2022 0,50 INR
13.09.2021 43,28 INR
17.09.2020 0,50 INR
12.09.2019 86,56 INR
14.08.2018 86,56 INR
18.09.2017 51,93 INR

Stock Splits

Date Split
26.09.2008 8:5
11.03.2008 25:4
28.09.2005 7:80

Ticker Symbols

Name Symbol
MSE BLISSGVS.BO
NSE BLISSGVS.NS
More Shares
Investors who hold Bliss GVS Pharma Limited also have the following shares in their portfolio:
ASS.BR.FOODS 22/34
ASS.BR.FOODS 22/34 Bond
KRANESHARES TRUST KRANESHARES EMERGING MARKETS HEALTHCARE INDEX ETF
KRANESHARES TRUST KRANESHARES EMERGING MARKETS HEALTHCARE INDEX ETF ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026